Osteoporosis is a condition of weak bone caused by a loss of bone mass and a change in bone structure. Glucocorticoid-induced osteoporosis is a form of osteoporosis caused by taking glucocorticoid medications, such as prednisone (Deltasone, Orasone, etc.), prednisolone (Prelone), dexamethasone (Decadron, Hexadrol), and cortisone (Cortone Acetate). These medications are used to help control many rheumatic diseases, including RA, systemic lupus erythematosus, and polymyalgia rheumatica.
Search results for: vitamin D
Reading Rheum: Which Bone Agent Is Best in High-risk Osteoporosis?
Handpicked Reviews of Contemporary Literature
Pursue Remission
Disease remission should be the goal for all rheumatologists treating childhood arthritis
State-of-the-Art Care for Your Practice
Clinical updates from the ACR Symposium
Medicare Quality Movement Reaches Clinicians
Physician Quality Reporting Initiative offers bonuses for clinicians and health professionals
Build Up Bone
Current management of osteoporosis
Have We Reached an Estrogen Comfort Zone?
A review of research on prescribing estrogens in systemic lupus erythematosus
Reading Rheum
Handpicked Reviews of Contemporary Literature
Coagulation Education: Treatment Options for Antiphospholipid Syndrome
Dr. Maria Tektonidou discussed the latest recommendations for the treatment of patients with antiphospholipid syndrome (APS), including obstetric and thrombotic subtypes.
Methotrexate Shows Promise for Hand Arthritis
Methotrexate—an affordable, established drug for rheumatoid arthritis—may also be helpful for patients suffering from osteoarthritis (OA) of the hand, a recent study reports.1 Treatment of hand OA and inflammation with 20 mg of methotrexate for six months had a moderate, but potentially clinically meaningful, effect on reducing pain and stiffness in patients with symptomatic hand…
- « Previous Page
- 1
- …
- 14
- 15
- 16
- 17
- 18
- …
- 23
- Next Page »